DCRI-BMS Data Sharing Initiative
The DCRI has partnered with Bristol-Myers Squibb (BMS) to expand access to clinical trial information from BMS-sponsored studies. Clinical trial information being made available for scientific research through SOAR™ includes protocols, full clinical study reports and de-identified patient-level data and study-level data for medicines and indications approved in the United States and/or Europe. Information from terminated programs will be available two years after discontinuation.
Each proposal is quickly reviewed by an Independent Review Committee with expertise in biostatistics, research ethics, patient privacy, and the clinical specialty of the research to evaluate the statistical analysis plan, plan to protect patient privacy, dissemination plan and qualification of the investigator(s). The data and analytical tools are provisioned directly to the investigator. The committee also reviews the final manuscript prior to submission to assess concordance with the stated analysis plan.
|Data Requests Received||57|
|Out of Scope||30|
|Out of Scope Reasons||Total|
|Not a BMS owned Asset||1|
|Not Approved for Marketing||3|
|Less than 2 Years Database Lock||9|
|Withdrawn by Requestor||3|
|Study Completed Before 2008||1|